Individuals with severe COVID-19 have demonstrated remarkably impaired type I IFN values as compared to mild patients (Hadjadj et al., 2020), and the interferon-induced overexpression of ACE2 may be involved (Ziegler et al., 2020). This evidence concerns the gene ACE2 and COVID-19.